AI assistant
BIO-TECHNE Corp — Director's Dealing 2019
Aug 21, 2019
30718_dirs_2019-08-21_880506ad-edc9-4116-9cc4-306dcc112c0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-08-19
Reporting Person: Kummeth Charles R. (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-08-19 | Common Stock | M | 24979 | — | Acquired | 135856 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-08-19 | Restricted Stock Units | $ | M | 24979 | Disposed | Common Stock (24979) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $67.46 | 2020-04-01 | Common Stock (57590) | 57590 | Direct |
| Stock Options (Right to Buy) | $86.25 | 2021-04-01 | Common Stock (46316) | 46316 | Direct |
| Stock Options (Right to Buy) | $94.35 | 2021-08-12 | Common Stock (66849) | 66849 | Direct |
| Stock Options (Right to Buy) | $108.49 | 2022-08-07 | Common Stock (79517) | 79517 | Direct |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (154169) | 154169 | Direct |
| Stock Options (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (102779) | 102779 | Direct |
| Restricted Stock Units | $ | Common Stock (21291) | 21291 | Direct | |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (117342) | 117342 | Direct |
| Stock Options (Right to Buy) | $125.05 | 2024-08-09 | Common Stock (78228) | 78228 | Direct |
| Restricted Stock Units | $ | Common Stock (16918) | 16918 | Direct | |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (90334) | 90334 | Direct |
| Stock Options (Right to Buy) | $177.32 | 2025-08-08 | Common Stock (60222) | 60222 | Direct |
| Restricted Stock Units | $ | Common Stock (16937) | 16937 | Direct | |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (85725) | 85725 | Direct |
| Stock Options (Right to Buy) | $190.41 | 2026-08-07 | Common Stock (57150) | 57150 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: Includes (i) 4,732 shares of restricted stock for which the risk of forfeiture will lapse on August 9, 2020; (ii) 7,519 shares of restricted stock for which the risk of forfeiture will lapse as to 3,760 shares on August 8, 2020 and as to 3,759 shares on August 8, 2021; and (iii) 11,291 shares of restricted stock for which the risk of forfeiture will lapse with respect to 3,764 shares on each of August 7, 2020 and August 7, 2021 and as to 3,763 shares on August 7, 2022.
F3: Fully exercisable.
F4: On 8/19/2019, the Board of Directors certified vesting of 24,979 performance RSUs.
F5: Options to purchase 25,695 shares vest on each of 8/18/2017, 8/18/2018 and 8/18/2019 and options to purchase 25,695 shares vest on 8/18/2020.
F6: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Options to purchase 19,557 shares vest on each of 8/9/2018, 8/9/2019, 8/9/2020 and 8/9/2021.
F8: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9: Options to purchase 15,056 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 15,055 shares vest on each of 8/8/2021 and 8/8/2022.
F10: Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F11: Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.